These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Platelet transfusion refractoriness and effective management of platelet alloimmunization]. Amemiya Y Nihon Rinsho; 1997 Sep; 55(9):2392-8. PubMed ID: 9301306 [TBL] [Abstract][Full Text] [Related]
4. [Alloimmunization and transfusion refractoriness to thrombocyte substitution]. Söhngen D; Schneider W Klin Wochenschr; 1991 Jul; 69(10):419-25. PubMed ID: 1942953 [TBL] [Abstract][Full Text] [Related]
5. Sensitization by platelet transfusion. Brand A Schweiz Med Wochenschr; 1991 Mar; 121(13):467-9. PubMed ID: 2031162 [TBL] [Abstract][Full Text] [Related]
6. Prevention of alloimmunization in patients with acute leukemia by use of white cell-reduced blood components--a randomized trial. Oksanen K; Kekomäki R; Ruutu T; Koskimies S; Myllylä G Transfusion; 1991 Sep; 31(7):588-94. PubMed ID: 1891788 [TBL] [Abstract][Full Text] [Related]
7. A new platelet-specific antigen, Naka, involved in the refractoriness of HLA-matched platelet transfusion. Ikeda H; Mitani T; Ohnuma M; Haga H; Ohtzuka S; Kato T; Nakase T; Sekiguchi S Vox Sang; 1989; 57(3):213-7. PubMed ID: 2617957 [TBL] [Abstract][Full Text] [Related]
8. [Effect of anti-HLA-A1 and anti-PLA1 antibodies on the efficacy of platelet transfusion]. Forest G Union Med Can; 1984 Jul; 113(7):607-9. PubMed ID: 6333099 [No Abstract] [Full Text] [Related]